Skip to main content
Premium Trial:

Request an Annual Quote

ReaX MDx

Q Chip this week announced the launch of its ReaX MDx PCR beads for molecular diagnostics.
According to the company, ReaX MDx beads, produced from organic and hydrogel polymers in Q Chip’s proprietary MicroPlant microfluidic device, eliminate the need for temperature-control logistics.
This features makes the beads “particularly suitable for oncology and infectious disease assays and point-of-care formats,” the company said in a statement this week.

Furthermore, since the MicroPlant device produces beads of less than 2 percent variability, the ReaX MDx assay yields consistently accurate results at low process costs, the company claimed. 

Filed under

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.